- Home
- ATNF
as 05-16-2025 4:00pm EST
180 Life Sciences Corp was formed as a clinical-stage biotechnology company, focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation, and fibrosis by employing research, and, where appropriate, combination therapy. In addition, it has acquired certain source code and intellectual property relating to the back-end technology platform to operate an online blockchain casino, and moving forward, it plans to focus the majority of its operations on the creation of the online blockchain casino, while looking to monetize certain prior development-stage therapeutic product candidates for unmet medical needs. It has one reportable operating segment, iGaming.
| Founded: | 2016 | Country: | United States |
| Employees: | N/A | City: | PALO ALTO |
| Market Cap: | 3.8M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 234.0K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -15.49 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.66 - $17.75 | Next Earning Date: | 05-27-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest 180 Life Sciences Corp. News
ATNF Breaking Stock News: Dive into ATNF Ticker-Specific Updates for Smart Investing
ACCESS Newswire
16 days ago
180 Life Sciences Corp. Announces Notice of Allowance for U.S. Patent Covering Novel Method to Prevent or Reduce Post-Operative Cognitive Dysfunction
ACCESS Newswire
17 days ago
180 Life Sciences Corp. Announces Share Repurchase
ACCESSWIRE
5 months ago
180 Life Sciences Corp. Announces Pricing of $2.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under NASDAQ Rules
ACCESSWIRE
5 months ago
180 Life Sciences Corp. Regains Full Compliance with Nasdaq Continued Listing Rules
ACCESSWIRE
5 months ago
180 Life Sciences Corp. Announces the Appointment of Stephen Shoemaker to Board of Directors
ACCESSWIRE
7 months ago
180 Life Sciences Corp. Retains Senior Technology Consultant and Commences Gaming Technology Platform Integration
ACCESSWIRE
7 months ago
180 Life Sciences Corp. Appoints Mr. Jay Goodman to Board of Directors
GlobeNewswire
7 months ago
Elray Resources Announces Strategic Sale of Crypto iGaming Technology
Compare ATNF vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ATNF 180 Life Sciences Corp. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.